Back to Search
PAMELA MILLER, PHARMD
PHARMD
Pharmacist
NPI: 1770666372Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
10232(NE)
Research & Publications (20)
Safe using messages may not be enough to promote behaviour change amongst injecting drug users who are ambivalent or indifferent towards death.
PMID 19630988·Harm Reduct J·2009
8-other
Diagnosis and treatment of osteoporosis in chronic renal disease.
PMID 19371805·Semin Nephrol·2009
6-review
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
PMID 18072873·J Bone Miner Res·2008
2-rct
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.
PMID 18539106·Bone·2008
3-trial
Effect of short-term diet and exercise on hormone levels and menses in obese, infertile women.
PMID 18567275·J Reprod Med·2008
3-trial
Febrile myoclonus: an underreported, benign condition in infancy often misinterpreted as febrile seizures.
PMID 18797372·Pediatr Emerg Care·2008
5-case
The cyclic "silver-diphos" motif [Ag2(mu-diphosphine)2]2+ as a synthon for building up larger structures.
PMID 18698693·Inorg Chem·2008
8-other
The role of bone biopsy in patients with chronic renal failure.
PMID 18988699·Clin J Am Soc Nephrol·2008
5-case
Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data.
PMID 18031594·Curr Med Res Opin·2008
6-review
Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts.
PMID 18708529·Protein Sci·2008
7-preclinical
Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study.
PMID 18042311·Curr Med Res Opin·2008
4-observational
Anti-resorptives in the management of osteoporosis.
PMID 19028360·Best Pract Res Clin Endocrinol Metab·2008
6-review
Safety of parathyroid hormone for the treatment of osteoporosis.
PMID 18430395·Curr Osteoporos Rep·2008
6-review
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
PMID 18682511·J Clin Endocrinol Metab·2008
2-rct
A pilot study using the internet to study patterns of party drug use: processes, findings and limitations.
PMID 17364852·Drug Alcohol Rev·2007
8-other
The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.
PMID 17698292·Biochim Biophys Acta·2007
7-preclinical
Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide.
PMID 17609307·J Clin Endocrinol Metab·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- NEBRASKA MEDICAL CENTER CLINIC PHARMACY, 989200 NEBRASKA MEDICAL CENTER
OMAHA, NE 68198 - Phone
- (402) 559-5106
Quick Facts
- NPI
- 1770666372
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile